| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/2010 | US20100168108 Phenyl derivatives and methods of use |
| 07/01/2010 | US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders |
| 07/01/2010 | US20100168106 Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation |
| 07/01/2010 | US20100168105 Spirocyclopropyl Piperidine Derivatives |
| 07/01/2010 | US20100168104 Hiv inhibiting 5-amido substituted pyrimidines |
| 07/01/2010 | US20100168103 Diaryl piperidine compounds as calcium channel blockers |
| 07/01/2010 | US20100168102 Amide Derivatives as Kinase Inhibitors |
| 07/01/2010 | US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/01/2010 | US20100168100 Quinoline derivatives as p13 kinase inhibitors |
| 07/01/2010 | US20100168099 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 07/01/2010 | US20100168098 Viral Polymerase Inhibitors |
| 07/01/2010 | US20100168097 Non-Nucleoside Reverse Transcriptase Inhibitors |
| 07/01/2010 | US20100168096 Acylguanidine derivative or salt thereof |
| 07/01/2010 | US20100168095 Multi-cyclic cinnamide derivatives |
| 07/01/2010 | US20100168094 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168093 Substituted 3-amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments |
| 07/01/2010 | US20100168092 Pharmaceutical composition with anti-diabetic action |
| 07/01/2010 | US20100168091 Imidazole Amines As Inhibitors Of Beta-secretase |
| 07/01/2010 | US20100168089 Utilization of tace inhibitors for the treatment of acne |
| 07/01/2010 | US20100168088 Pyrrolidine derivatives as nk-3 receptor antagonists |
| 07/01/2010 | US20100168087 Benzo[1,2,3]thiadiazine derivates |
| 07/01/2010 | US20100168086 7,8,10,10a-tetrahydro-6h-benzo[c]chromen-9(6ah)-one modulators of cannabinoid receptors |
| 07/01/2010 | US20100168085 Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells |
| 07/01/2010 | US20100168084 Therapeutic compounds and related methods of use |
| 07/01/2010 | US20100168083 Adamantane derivatives for the treatment of the metabolic syndrome |
| 07/01/2010 | US20100168082 Heterobicyclic Carboxamides as inhibitors for kinases |
| 07/01/2010 | US20100168081 Galantamine as a neuroprotective drug for retinal ganglion cells |
| 07/01/2010 | US20100168080 Novel compounds useful as cc chemokine receptor ligands |
| 07/01/2010 | US20100168079 Biaryl Benzylamine Derivatives |
| 07/01/2010 | US20100168078 S1p receptor modulators for treating multiple sclerosis |
| 07/01/2010 | US20100168077 Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof |
| 07/01/2010 | US20100168076 Diphenyl substituted alkanes |
| 07/01/2010 | US20100168075 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 07/01/2010 | US20100168074 Freezable Unit Dosage Delivery System and Method of Preparation |
| 07/01/2010 | US20100168073 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 07/01/2010 | US20100168072 Drug Combinations for the Treatment of Duchenne Muscular Dystrophy |
| 07/01/2010 | US20100168071 Extended estrogen dosing contraceptive regimen |
| 07/01/2010 | US20100168070 Compounds for the treatment of alzheimer's disease |
| 07/01/2010 | US20100168068 Mao-b inhibitors useful for treating obesity |
| 07/01/2010 | US20100168067 Biomarkers for bisphosphonate-responsive bone disorders |
| 07/01/2010 | US20100168065 Quinolinone derivatives as parp and tank inhibitors |
| 07/01/2010 | US20100168064 Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents |
| 07/01/2010 | US20100168063 Bicyclic pyrimidinones and uses thereof |
| 07/01/2010 | US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors |
| 07/01/2010 | US20100168061 Method for preparing enzymatically highly branched-amylose and amylopectin cluster |
| 07/01/2010 | US20100168060 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 07/01/2010 | US20100168059 Hyaluronic acid nutritional supplements and methods of using the same |
| 07/01/2010 | US20100168058 Novel antagonists of the toll-like receptor 4 |
| 07/01/2010 | US20100168057 Fungal growth inhibitor |
| 07/01/2010 | US20100168056 Dietary fiber formulation and method of administration |
| 07/01/2010 | US20100168054 Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation |
| 07/01/2010 | US20100168053 Oral delivery system for methylcobalamin to treat disorders |
| 07/01/2010 | US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation |
| 07/01/2010 | US20100168051 Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress |
| 07/01/2010 | US20100168050 Compounds having antiangiogenic activity |
| 07/01/2010 | US20100168048 Method of Stabilizing S-Adenosyl-L-Methionine and Stabilized Composition |
| 07/01/2010 | US20100168047 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics |
| 07/01/2010 | US20100168046 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
| 07/01/2010 | US20100168044 Superparamagnetic nanoparticle encapsulated with stimuli responsive polymer for drug delivery |
| 07/01/2010 | US20100168029 Methods for treating bone tumors |
| 07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/01/2010 | US20100168020 Stabilized receptor polypeptides and uses thereof |
| 07/01/2010 | US20100168016 Diagnosis and treatment of diseases caused by misfolded proteins |
| 07/01/2010 | US20100168010 Compositions and methods of modulating cell growth and motility |
| 07/01/2010 | US20100168005 Pyridin-3-yl derivatives as immunomodulating agents |
| 07/01/2010 | US20100168004 Methods and compositions for the synergistic activation of latent hiv |
| 07/01/2010 | US20100168003 Agent for Treating Polyglutamine Aggregation-Caused Disease or Suppressing Onset Thereof |
| 07/01/2010 | US20100167994 Targeting of ews-fli1 as anti-tumor therapy |
| 07/01/2010 | US20100167993 Compounds for Enhancing p21 Expression and Methods of Use Thereof |
| 07/01/2010 | US20100167992 Phenyl Ester Side Chains to Increase Polymer Resorptivity |
| 07/01/2010 | US20100167989 Isopropoxyphenylmethyl inhibitors of sglt2 |
| 07/01/2010 | US20100167988 Ethoxyphenylmethyl inhibitors of sglt2 |
| 07/01/2010 | US20100167987 Methods and pharmaceutical compositions for healing wounds |
| 07/01/2010 | US20100167986 Cholesteryl Ester Transfer Protein Inhibitors |
| 07/01/2010 | US20100167982 Barrier integrity in hiv patients |
| 07/01/2010 | US20100167981 Encapsidation of Heterologous Entities into Virus-Like Particles |
| 07/01/2010 | US20100167980 Prolyl Endopeptidase Inhibitors For Reducing or Preventing Neutrophilic Inflammation |
| 07/01/2010 | US20100167936 Use of ascorbic acid derivatives for the functionalization of matrices |
| 07/01/2010 | US20100167927 Substituted Amino-Thiourea Compounds For Combating Animal Pests |
| 07/01/2010 | US20100167321 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same |
| 07/01/2010 | US20100166898 Anti-bacterial use of extract from morus australis poir. and compound kuwanon h |
| 07/01/2010 | US20100166893 Herbal composition for reducing add/adhd and method thereof |
| 07/01/2010 | US20100166889 Method of treating depressive disorders |
| 07/01/2010 | US20100166888 Composition and method for the control of organoleptic properties of bodily fluids and secretions |
| 07/01/2010 | US20100166887 DIBENZO[b,e][1,4]DIAZEPINE MODULATORS OF DOPAMINE RECEPTORS, SEROTONIN RECEPTORS, ADRENERGIC RECEPTORS, ACETYLCHOLINE RECEPTORS, AND/OR HISTAMINE RECEPTORS |
| 07/01/2010 | US20100166886 Methods of treating the skin |
| 07/01/2010 | US20100166884 Potentiation of cancer chemotherapy by 7-(2, 5- dihydro- 4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine |
| 07/01/2010 | US20100166883 Compositions for accelerating the production of collagen-containing proteins |
| 07/01/2010 | US20100166881 Novel IDO Inhibitors and Methods of Use Thereof |
| 07/01/2010 | US20100166880 Method for treatment and diagnosis of glutamate dehydrogenase disorders |
| 07/01/2010 | US20100166876 Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
| 07/01/2010 | US20100166874 Technology for Preparation of Macromolecular Microspheres |
| 07/01/2010 | US20100166873 Eutectic-Based Self-Nanoemulsified Drug Delivery System |
| 07/01/2010 | US20100166872 Novel improved compositions for cancer therapy |
| 07/01/2010 | US20100166869 Methods and compositions for treating pulmonary hypertension |
| 07/01/2010 | US20100166866 Matrix compositions for controlled delivery of drug substances |
| 07/01/2010 | US20100166865 Nanoparticle compositions |
| 07/01/2010 | US20100166864 Matrix-based pulse release pharmaceutical formulation |
| 07/01/2010 | US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders |
| 07/01/2010 | US20100166861 Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone |